Median enhances cancer lesion software

Median Technologies has updated its Median LMS (Lesion Management Solution) software to
evaluate, follow and report on changes involving of cancerous lesions seen on CT images from the neck to the pelvis. The enhanced software, slated to debut at RSNA 2009, generates a single report for the quantitative management of patient response to therapy, according to the company. It is designed for routine clinical use, as well as in multicenter clinical trials. Median LMS automates the initial evaluation and follow-up of cancerous lesions identified in CT images of the thorax, abdomen and pelvis, automatically generating a standardized oncologic report and centralizing all lesion information. In so doing, it helps in the assessment of patient response to therapy, assisting in an evaluation of the effectiveness drugs. This can be especially important in clinical trials, when experimental drugs require standardized measurement and reporting of target lesion response, according to the company.